Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/18/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 5k | $57.18 | $285.9k | | 08/18/2023 |
08/18/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (Right to Buy) | 5k | $15.04 | $75.2k | | 08/18/2023 |
07/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 4k | $68.96 | $273.5k | | 07/19/2023 |
07/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1k | $70.08 | $72.5k | | 07/19/2023 |
07/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 5k | $15.04 | $75.2k | | 07/19/2023 |
06/30/2023 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Common Stock | 21.2k | $0.00 | $0 | | 06/30/2023 |
06/30/2023 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 42.4k | $0.59 | $25k | | 06/30/2023 |
05/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2.8k | $73.63 | $207.9k | | 05/19/2023 |
05/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2.2k | $74.47 | $162.1k | | 05/19/2023 |
05/19/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 5k | $15.04 | $75.2k | | 05/19/2023 |
03/20/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 3.9k | $47.51 | $185.4k | | 03/20/2023 |
03/20/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.1k | $48.47 | $53.2k | | 03/20/2023 |
03/20/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 5k | $15.04 | $75.2k | | 03/20/2023 |
03/15/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 9.4k | $48.14 | $454k | | 03/15/2023 |
03/15/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 10.6k | $48.66 | $514.3k | | 03/15/2023 |
03/15/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 20k | $15.04 | $300.8k | | 03/15/2023 |
03/02/2023 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (Right to Buy) | 38k | $52.97 | $2M | | 03/02/2023 |
11/18/2022 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 9.8k | $57.04 | $557.5k | | 11/18/2022 |
11/18/2022 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 226 | $58.27 | $13.2k | | 11/18/2022 |
11/18/2022 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 10k | $15.04 | $150.4k | | 11/18/2022 |
02/23/2022 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (Right to Buy) | 45.5k | $32.45 | $1.5M | | 02/23/2022 |
11/23/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 4.5k | $15.04 | $68k | | 11/23/2021 |
11/23/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.8k | $58.43 | $106.3k | | 11/23/2021 |
11/23/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2.7k | $57.51 | $155.3k | | 11/23/2021 |
10/20/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3k | $29.81 | $89.4k | | 10/20/2021 |
10/20/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 19.1k | $60.00 | $1.1M | | 10/20/2021 |
10/20/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.7k | $60.91 | $103.5k | | 10/20/2021 |
10/20/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2.2k | $61.94 | $135.3k | | 10/20/2021 |
10/20/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 20k | $15.04 | $300.8k | | 10/20/2021 |
06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 2.4k | $6.69 | $15.9k | | 06/15/2021 |
06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Stock Option (right to buy) | 4.7k | $6.69 | $31.8k | | 06/15/2021 |
06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Common Stock | 1.2k | $0.00 | $0 | | 06/15/2021 |
06/15/2021 | Cyclacel Pharmaceuticals, Inc. | CYCC | Grant | Common Stock | 2.4k | $0.00 | $0 | | 06/15/2021 |
02/25/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Employee Stock Option (Right to Buy) | 28k | $22.60 | $632.8k | | 02/25/2021 |
02/12/2021 | PROTHENA CORP PUBLIC LTD CO | PRTA | Disposition | Employee Stock Option (Right to Buy) | 17.5k | $27.81 | $486.7k | | 02/12/2021 |
|